Literature DB >> 28697953

3D in vitro models of liver fibrosis.

Leo A van Grunsven1.   

Abstract

Animal testing is still the most popular preclinical assessment model for liver fibrosis. To develop efficient anti-fibrotic therapies, robust and representative in vitro models are urgently needed. The most widely used in vitro fibrosis model is the culture-induced activation of primary rodent hepatic stellate cells. While these cultures have contributed greatly to the current understanding of hepatic stellate cell activation, they seem to be inadequate to cover the complexity of this regenerative response. This review summarizes recent progress towards the development of 3D culture models of liver fibrosis. Thus far, only a few hepatic culture systems have successfully implemented hepatic stellate cells (or other non-parenchymal cells) into hepatocyte cultures. Recent advances in bioprinting, spheroid- and precision-cut liver slice cultures and the use of microfluidic bioreactors will surely lead to valid 3D in vitro models of liver fibrosis in the near future.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bioreactor; Coculture; Drug induced liver injury; Hepatic stellate cell; Hepatocyte damage; Spheroid cultures

Mesh:

Year:  2017        PMID: 28697953     DOI: 10.1016/j.addr.2017.07.004

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  28 in total

1.  Applications of novel bioreactor technology to enhance the viability and function of cultured cells and tissues.

Authors:  H W Hoyle; L A Smith; R J Williams; S A Przyborski
Journal:  Interface Focus       Date:  2020-02-14       Impact factor: 3.906

2.  Recent Advances in Body-on-a-Chip Systems.

Authors:  Jong Hwan Sung; Ying I Wang; Narasimhan Narasimhan Sriram; Max Jackson; Christopher Long; James J Hickman; Michael L Shuler
Journal:  Anal Chem       Date:  2018-12-11       Impact factor: 6.986

Review 3.  Hepatic Stellate Cell: A Double-Edged Sword in the Liver.

Authors:  Nianan Luo; Jiangbin Li; Yu Wei; Jianguo Lu; Rui Dong
Journal:  Physiol Res       Date:  2021-10-30       Impact factor: 1.881

4.  Engineering Modular 3D Liver Culture Microenvironments In Vitro to Parse the Interplay between Biophysical and Biochemical Microenvironment Cues on Hepatic Phenotypes.

Authors:  Alex J Wang; Allysa Allen; Marianna Sofman; Pierre Sphabmixay; Ece Yildiz; Linda G Griffith
Journal:  Adv Nanobiomed Res       Date:  2021-11-19

5.  Differential fibrotic phenotypes of hepatic stellate cells within 3D liver organoids.

Authors:  Matthew Brovold; Dale Keller; Shay Soker
Journal:  Biotechnol Bioeng       Date:  2020-05-23       Impact factor: 4.530

Review 6.  Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment.

Authors:  Mariia Zadorozhna; Sante Di Gioia; Massimo Conese; Domenica Mangieri
Journal:  Mol Biol Rep       Date:  2020-02-10       Impact factor: 2.316

Review 7.  Liver-on-a-Chip Models of Fatty Liver Disease.

Authors:  Shabir Hassan; Shikha Sebastian; Sushila Maharjan; Ami Lesha; Anne-Marie Carpenter; Xiuli Liu; Xin Xie; Carol Livermore; Yu Shrike Zhang; Ali Zarrinpar
Journal:  Hepatology       Date:  2020-02       Impact factor: 17.425

Review 8.  Hepatic stellate cells as key target in liver fibrosis.

Authors:  Takaaki Higashi; Scott L Friedman; Yujin Hoshida
Journal:  Adv Drug Deliv Rev       Date:  2017-05-12       Impact factor: 17.873

Review 9.  Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.

Authors:  Fanglong Wu; Jin Yang; Junjiang Liu; Ye Wang; Jingtian Mu; Qingxiang Zeng; Shuzhi Deng; Hongmei Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-06-10

Review 10.  In Vitro Strategies to Vascularize 3D Physiologically Relevant Models.

Authors:  Alessandra Dellaquila; Chau Le Bao; Didier Letourneur; Teresa Simon-Yarza
Journal:  Adv Sci (Weinh)       Date:  2021-08-05       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.